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Environmental tobacco smoke (ETS) has been recognized as a major health hazard by
environmental and public health authorities worldwide. In Portugal, smoke-free laws are
in force for some years, banning smoking in most indoor public spaces. However, in
hospitality venues such as restaurants and bars, owners can still choose between a
total smoke-free policy or a partial smoking restriction with designated smoking areas,
if adequate reinforced ventilation systems are implemented. Despite that, a previous
study showed that workers remained continuously exposed to higher ETS pollution in
Lisbon restaurants and bars where smoking was still allowed, comparatively to total
smoke-free venues. This was assessed by measurements of indoor PM2.5 and urinary
cotinine, a biomarkers of tobacco smoke exposure, demonstrating that partial smoking
restrictions do not effectively protect workers from ETS. The aim of the present work
was to characterize effect and susceptibility biomarkers in non-smokers from those
hospitality venues occupationally exposed to ETS comparatively to non-exposed ones.
A group of smokers was also included for comparison. The sister chromatid exchange
(SCE), micronucleus (MN) and comet assays in whole peripheral blood lymphocytes
(PBLs) and the micronucleus assay in exfoliated buccal cells, were used as biomarkers
of genotoxicity. Furthermore, a comet assay after ex vivo challenge of leukocytes with an
alkylating agent, ethyl methanesulfonate (EMS), was used to analyze the repair capacity
of those cells. Genetic polymorphisms in genes associated with metabolism and DNA
repair were also included. The results showed no clear association between occupational
exposure to ETS and the induction of genotoxicity. Interestingly, the leukocytes from
non-smoking ETS-exposed individuals displayed lower DNA damage levels in response
to the ex vivo EMS challenge, in comparison to those from non-exposed workers,
suggesting a possible adaptive response. The contribution of individual susceptibility to
the effect biomarkers studied was unclear, deserving further investigation.
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INTRODUCTION
Environmental tobacco smoke (ETS), also known as second-
hand smoke (SHS), passive smoke or involuntary smoke is a
widespread indoor pollutant of significant public health concern,
and a major risk factor for lung cancer and other diseases (1–
5). The mutagenic and carcinogenic effects of tobacco smoke
have been clearly demonstrated (1, 2, 6, 7) and its adverse
effects are not limited to smokers, but affect also environmentally
and occupationally exposed non-smokers, since it is present in
all places where smoking takes place (2). ETS is a significant
source of a complexmixture of hundreds of hazardous substances
comprising the smoke emitted from the burning tip of a cigarette
(or other burned tobacco product) between puffs (sidestream
smoke, SM), the smoke exhaled by the smoker (mainstream
smoke, MS), and also the compounds diffused through the
cigarette paper wrapper (1, 2, 8). ETS is classified as carcinogenic
to humans (group 1) by the International Agency for Research
on Cancer (1, 2), based on a clear evidence of a causal association
between exposure of non-smokers and cancer. Because of its
rapid dilution and dispersion into the indoor environment, the
concentrations of individual ETS constituents can vary with time
and environmental conditions (1, 2), and currently there is no
safe level of exposure to ETS (9). While social ETS exposure
can be controllable (an individual may avoid to be in places
where smokers are present), employees, however, have little or
no influence over ETS and may be exposed for a large part
of their working day (10). Occupational exposure to ETS was
associated with an increase of 16–19% in the risk of lung cancer
among never-smokers (1). Comprehensive smoke-free laws offer
the only effective means of eliminating the risks associated with
ETS (9). In fact, to protect people from ETS, since 2005, smoke-
free policies have been expanding worldwide covering indoor
public places and workplaces, including hospitality venues (9,
11, 12) and overall have been highly effective in reducing
the exposure to constituents of ETS (5, 11, 13, 14), as well
as decreasing ETS-related diseases (12, 15), particularly when
complete smoke-free ban is applied. Nonetheless, ETS remains
a common indoor air pollutant, especially in indoor leisure
areas including restaurants, bars, nightclubs and casinos (9,
16–18). In Portugal, the law that prohibits smoking in most
indoor public spaces and workplaces was introduced in 2008,
but in some cases, such as restaurants and bars, partial smoking
restrictions are applied, and smoking is still allowed in separate
designated smoking areas if adequate reinforced ventilation
systems are implemented. Whether the health of the ETS-
exposed workers is affected remained an open question. A
previous work by Pacheco et al. (17) showed that ETS indoor
pollution, estimated by the concentration of particulate matter
(PM2.5), was consistently higher in restaurants where smoking
was still allowed, comparatively to non-smoking restaurants
and canteens (total smoke-free). In addition, the measurement
of a biomarker of tobacco smoke exposure, i.e., cotinine, a
metabolite of nicotine, confirmed the employees’ exposure to
ETS. Although all workers exhibited normal lung function, a
proteomics approach identified differentially expressed proteins
in the plasma of those ETS-exposed non-smoking workers,
suggestive of alterations that may precede the first symptoms of
tobacco-related diseases (19).
It is acknowledged that many substances contained in
cigarette smoke are genotoxic and therefore genotoxicity
biomarkers are good biomarkers to assess early effects from
exposure to tobacco smoke (8, 20, 21), including ETS. The
genotoxicity of ETS exposure has been addressed in few in-vitro,
in-vivo and biomonitoring studies (8). In humans, environmental
room exposure studies using fresh diluted sidestream smoke as
a surrogate to estimate the effect of ETS exposure showed a
slightly increased urinary mutagenicity (22) and DNA damage
(23) in non-smoking voluntaries. Importantly, some studies
reported the presence of DNA adducts (24), protein adducts (25–
28) and urinary metabolites of carcinogens (29–31) after ETS
exposure. On the other hand, biomonitoring studies evidencing
the genotoxic effects of ETS on humans are scarce. While for
chromosome instability results were predominantly negative
(32–36), for the induction of DNA strand breaks, both positive
(37, 38) and negative (39) results are described, although in the
majority of those studies cotinine measurements confirmed the
ETS exposure. A more evident genotoxic effect of ETS exposure
appears to happen in children. A marginally significant increases
of sister chromatid exchange (27), micronucleus (25, 40) and
DNA damage measured with the comet assay (41–43) was
reported. In the occupational settings, the impact of ETS on the
genotoxicity biomarkers remains to be clarified.
The aim of the present work was to characterize the local
and systemic genotoxic effects induced by occupational exposure
to ETS in non-smoking workers from Lisbon restaurants and
bars and to assess whether the genetic susceptibility could
influence the observed effects. The sister chromatid exchange,
micronucleus and comet assays in PBLs and the micronucleus
assay in exfoliated buccal cells, were used to assess DNA and
chromosome damage in ETS-exposed workers comparatively
to non-exposed workers from the previously characterized
hospitality venues (17, 19). A group of smokers working in the
same venues was also included for comparison. In addition,
the capacity of leukocytes to repair DNA lesions was estimated
by the comet assay following their ex vivo exposure to an
alkylating agent, ethyl methanesulfonate. Because several studies
have evidenced the influence of genetic polymorphisms in genes
encoding for metabolizing enzymes or DNA repair proteins
on smoking-associated biomarkers, genotoxicity biomarkers and
cancer predisposition (20, 44–50), some relevant susceptibility
biomarkers were also studied. These included polymorphisms
in metabolism (GSTP1105, GSTM1, and GSTT1) and DNA
repair (hOGG1326, XRCC1194, XRCC1399, XRCC3241, NBN185,
PARP1762) genes.
MATERIALS AND METHODS
Workplace Characterization and Study
Population
Among leisure establishments in Lisbon, restaurants and
bars/discotheques were preselected based on a convenience
sample. Accordingly, 58 main venues’ owners were invited
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to participate in the study by letter and personal approach.
After detailed information of project objectives, 25 agreed to
participate in the study. Venues were classified as smoke-free
(SFre), smoking (Sre) and mixed restaurants and bars with both
smoking (Sro) and non-smoking rooms (NSro), as previously
described by Pacheco et al. (17). In addition, four public
institutions canteens (Cant) where smoking was not allowedwere
also included. ETS was assessed by monitoring the level of indoor
air contaminants, namely, particulate matter (PM2.5), CO and
CO2 in all venues and a full description of the methods and
results obtained can be found elsewhere (17, 19).
To estimate the adequate sample size of the study groups,
a power analysis was performed based on the frequency of
micronuclei (MN) in lymphocytes, a sensitive biomarker of an
early biological effect. Based on published and our own data from
control groups, the mean frequency of MN was expected to be
7.0/1,000 cells and the SD = 3.0. An 80% power is generally
considered as acceptable (51). To obtain a two-tailed p-value of
0.05 and a difference between the exposed and control groups
that corresponds to a 25% higher mean level of MN among
the exposed, a minimum of 49 subjects would be needed in
each group; if the difference increases to 30%, 33 subjects would
be needed. Despite the estimates made and the invitation to
participate to a larger number of employees, only 97 accepted to
provide blood and buccal cells samples for genotoxic assessment.
Ethics approval for this study was secured from Instituto
Nacional de Saúde Dr. Ricardo Jorge (INSA) ethics committee,
Lisbon. Each potential participant was informed about the
procedures and the objectives of the study and those who
accepted to participate provided written informed consent
for the collection and utilization of biological specimens.
During the medical surveillance phase of the study, each
subject was interviewed to evaluate clinical history, demographic
and lifestyle information, particularly about smoking habits
(including amount, frequency, and duration of smoking) or self-
reported exposure to ETS at home. According to the inclusion
criteria, healthy subjects with more than 18 years, who worked in
the above referred hospitality venues for more than 9 h per week
and for at least 1 month at the current workplace were included
in the study. Excluded were the individuals submitted to X-rays,
blood transfusion or surgery between 0 and 2 months before the
study and those who suffer or had suffered from cancer. Thus,
from the 97 volunteers preselected, 81 were included in effect and
susceptibility biomarkers analysis. Detailed contextual data can
be found in Pacheco et al. (19).
Workers were separated into three study groups according to
smoking status and ETS occupational exposure as follow: a group
of non-smoking workers (NSW, n = 62) that was subdivided
according to ETS exposure on the workplace into the ETS-
exposed group (E, n = 29) including workers from Sre or mixed
restaurants and bars and the non-exposed group (NE, n = 33)
including workers from SFre and Cant; a group of smoking
workers (SW, n = 19) containing workers from SFre and from
Sre or mixed venues (17).
Human exposure to ETS and confirmation of smoking habits
had been previously assessed by urinary cotinine levels, allowing
to discriminate between smokers and non-smokers and between
non-smokers exposed and not exposed to ETS. A full description
of the methods and results obtained can be found elsewhere
(17, 19).
Biological Samples Collection
Following the interview and medical examination, biological
samples were collected and coded to ensure their anonymization.
For effect biomarkers characterization, peripheral blood and
buccal epithelial cells samples were collected from each subject
by medical personnel. Two mL of peripheral blood was collected
by venipuncture into heparin-coated tubes and were processed
within 2–3 h for SCE, MN and comet assays. Each subject was
then asked to rinse the mouth twice with water and buccal
epithelial cells were collected by gently scraping the oral mucosa
of the inner lining of both cheeks with a plastic spatula. For
genotyping of genetic polymorphisms, 2mL of peripheral blood
was collected into EDTA tubes, also by venipuncture.
The Alkaline Comet Assay in Peripheral
Blood Lymphocytes
The alkaline version of the comet assay was used to evaluate
DNA damage in PBLs from each subject and was carried out
as described elsewhere (52), with some modifications. Briefly,
20 µL of whole blood was added to a 1ml phosphate-buffered
saline (PBS, Gibco-Invitrogen, Carlsbad, CA). Cells were pelleted
and 40 µL were embedded in 0.7% low-melting point agarose
(Sigma, St. Louis, MO) and then dropped onto microscope slides
pre-coated with 1% agarose (Amersham Biosciences, Uppsala,
Sweden) and covered with a coverslip for about 10min, at 4◦C.
Simultaneously, to test the response of PBLs to an ex vivo
challenge, 20 µL of whole blood was added to 1ml PBS (Gibco-
Invitrogen) and exposed to 32mM of ethyl methanesulfonate
(EMS, Sigma), incubated at 37◦C for 30min, and equally
processed. After gel solidification, coverslips were removed and
slides were immersed in freshly prepared ice-cold lysis solution
(2.5M NaCl, 100mM Na2EDTA.H20, 10mM Tris HCL, NaOH,
pH 10) with 10% Dimethyl Sulfoxide (DMSO, Sigma) and
1% Triton X-100 (Sigma), for 1 h, at 4◦C, in the dark. After
lysis, slides were placed on a horizontal electrophoresis tank
in an ice bath, immersed in alkaline electrophoresis buffer
(300mM NaOH, 1mM Na2EDTA.2H2O, pH>13) in the dark,
for 20min, to allow DNA unwinding. Electrophoresis was
then conducted at 25V (∼0.74 V/cm, 300mA), at 4◦C for
20min. Then, slides were rinsed with the neutralization buffer
(0.4M Tris–HCl, pH 7.5), stained with 125µg/mL ethidium
bromide (Sigma), covered with a coverslip, and kept in a dark,
moist chamber. Two slides were prepared for each subject and
a “blind” scorer examined 50 randomly selected cells from
each slide (100 cells/subject) using a 200× magnification in
a Axioplan2 imaging epifluorescence microscope (Carl Zeiss
Microscopy, Göttingen, Germany) with an image analysis
system (Comet Imager 2.2 Software, MetaSystems, Altlussheim,
Germany). The mean percentage of DNA in the nucleoids
tail (tail DNA,%) and the tail length (TL) were calculated for
each worker.
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Micronucleus Analyses in Peripheral Blood
Lymphocytes
The Cytokinesis-blocked micronucleus assay (CBMN) was
carried out as described elsewhere (53) withminormodifications.
Briefly, whole blood samples (0.5mL) from each subject were
cultured in 4.5mL RPMI-1640 medium with L- Glutamate
(Gibco-Invitrogen) supplemented with Fetal Bovine Serum (25%,
Sigma), phytohemaglutinin (2.5%, Gibco-Invitrogen), Penicillin-
Streptomycin (1.5% Gibco-Invitrogen) and sodium heparin
(0.5%, B. Braun Medical, Germany). Duplicate cultures from
each subject were incubated at 37◦C, for 68 h. Cytokinesis was
blocked at 44 h of incubation by adding 5µg/mL of cytochalasin
B (Sigma-Aldrich, St. Louis, MO). After the 68 h of incubation,
cells were harvested by treatment with a hypotonic solution
(0.1M KCl), at 37◦C, followed by fixation (methanol: acetic
acid, 3:1). Cells were immediately dropped onto microscope
slides using cytocentrifugation, air-dried and stained with 4%
Giemsa (Merck, Darmstadt, Germany) in pH 6.8 phosphate
buffer. MN were blindly scored, under a bright field microscope
(Axioskop 2 Plus, Zeiss, Germany) with a 400× magnification,
and identified according to published criteria (54). From each
subject at least one thousand binucleated cells (BC) with well-
preserved cytoplasm (500 per replicate culture) were analyzed
and the frequency of micronucleated binucleated cells per
1000 binucleated cells (MNBC/1000 BC) was calculated and
represented as the mean number of MNBC/1000 BC ± SD.
The proportion of mono- (MC), bi- (BC) or multinucleate
cells (MTC) was determined in a total of 1,000 cells and the
cytokinesis-block proliferation index (CBPI) was calculated as
follows (55):
CBPI= (MC+ 2BC+ 3MTC)/Total Cells.
Sister-Chromatid Exchange Analyses in
Peripheral Blood Lymphocytes
For the SCE analysis in PBLs, cultures were established in
duplicate as described previously (56), with minor modifications.
One mL of whole blood were added to 9mL RPMI-1640
culture medium supplemented as described above for the
CBMN. Bromodeoxyuridine (BrdU, Sigma) was added to a
final concentration of 10µg/mL and incubated at 37◦C for
56 h, in the dark. Cultures were treated with 0.1 mg/mL
colcemid (Gibco-Invitrogen), 1 h prior to harvesting. Cells were
processed through hypotonic treatment (0.075M KCl) and
fixation withmethanol:acetic acid (3:1). Slides were prepared, air-
dried and stained using the fluorescence plus Giemsa method
(56, 57) for differential sister chromatids staining. For each
subject, SCEs were analyzed in 50 second-division metaphases
from two cultures, on coded slides, to determine the number
of SCE per cell, and mean and standard deviation of the
SCE counts per cell were calculated. The number of high
frequency cells (HFCs) for each subject was determined as
the proportion of metaphases whose SCE frequency exceeds
the 95th percentile of the SCE distribution in the NE
group, which was defined as those with a count of 14 or
more SCEs.
Micronucleus Analysis in Buccal Exfoliated
Epithelial Cells
Buccal exfoliated epithelial cells were smeared onto slides, air-
dried and fixed in 80% coldmethanol, for 20min (58). Slides were
stained according to Feulgen’s technique (59) without cytoplasm
counterstain. Two thousand cells were scored on two slides (one
from each cheek) from each individual (1000 cells per slide) based
on published criteria (58, 59). Only cells containing an intact
nucleus that was neither clumped nor overlapping were included
in the analysis. The frequencies of micronucleated cells (MNC)
and nuclear buds (NBUD) per 1000 cells were determined for
each subject and represented as the mean number of MNC/1000
cells± SD and NBUD/1000 cells± SD, respectively.
Genetic Polymorphisms in Metabolism and
DNA Repair Genes
Genomic DNA was isolated from whole blood samples of
the workers with the MagNA Pure LC DNA Isolation Kit
(Roche Applied Science, Germany) following the manufacturer’s
instructions. DNA samples were stored at −20◦C until analysis.
Genetic polymorphisms in metabolism (GSTP1105, GSTM1, and
GSTT1) and DNA repair (hOGG1326, XRCC1194, XRCC1399,
XRCC3241, NBN185, and PARP1762) genes were analyzed using
PCR-based assays, according to published methods with minor
modifications. GSTT1 and GSTM1 genotype analysis was
performed in the same reaction, in a multiplex PCR (60).
DNA amplification by PCR with specific primers flanking
the polymorphism, followed by enzymatic restriction and
fragments’ analysis by gel electrophoresis, i.e., the PCR-RFLP
method, was used to characterize the following polymorphisms:
GSTP1105 (61), hOGG1326 (62), XRCC1194(63), XRCC1399(63),
XRCC3241(64), NBN185(65), and PARP1762 (66). The details
of the primers, restriction enzymes, and PCR conditions are
described in the Supplementary Table 1.
Statistical Analysis
All statistical analyses were conduct using the IBM SPSS 17.0 for
Windows statistical package. The level of significance considered
was p< 0.05. The distribution of variables in total population and
divided by groups was compared with the normal distribution by
means of the Kolmogorov–Smirnov test. The studied variables
MNBC/1000 BC cells, CBPI, MNC/1000 cells, NBUD/1000 Cells,
SCE frequencies,% tail DNA, and TL departed significantly from
normality and therefore non-parametric tests were applied. Chi-
square test was applied to compare the frequency of MNBC/1000
BC and the frequency of MNC/1000 cells or NBUD/1000
cells in buccal epithelial cells between exposure groups. The
frequencies of SCEs, HFCs, CPBI,% tail DNA and TL from
each group were compared using the non-parametric Mann-
Whitney U-test. The relationship between the biomarkers of
early biological effects (MN and SCE frequencies, % tail DNA)
and the duration of exposure to cigarette smoke (active and
passive), cigarette consumption (number of cigarettes per day),
cotinine concentration and age was explored by Spearman’s
correlation analysis. The same analysis was also used to explore
correlations between the several effect biomarkers analyzed. The
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effect of gender on the cytogenetic parameters or in the genetic
polymorphism was assessed by the Mann–Whitney U-test.
Regarding the genetic polymorphisms, deviation from Hardy–
Weinberg (HW) equilibrium was assessed with the Chi-Square-
test. Statistical analysis using Pearson Chi-Square (2-sided), or
two-sided Fisher’s exact test were applied to assess differences
between studied groups concerning allele distributions. To assess
the influence of the genotype on each effect biomarker, non-
parametric tests (Kruskal–Wallis orMann–WhitneyU-test) were
applied. Two types of comparisons were made: the influence of
the gene variants on the biomarker level within each exposure
group and inter-group comparison according to each allelic
variant. Due to the low number of homozygous variant carriers
of XRCC1194, XRCC1399, PARP1762, and XRCC3241, all subjects
harboring variant alleles (homozygous and heterozygous) were
pooled together.
RESULTS
Characteristics of the Study Population
General characteristics of the studied groups are described in
Table 1. The studied population consisted of 81 workers, the
majority being males (74%). The mean age was 45.2 ± 12.2
years for the NE group, 37.2 ± 10.8 years for the E group
and 39.1 ± 11.1 years for SW. Mean age in the NE group
was significantly higher than in E group (p = 0.008, unpaired
t-test). Most employees stated to work at least 40 h per week
(NE: 48.9 h ± 12.3; E: 39.1 ± 9.7 h; SW: 47.5 ± 12.6 h). Mean
h per week in the E group was significantly lower than in NE
group (p < 0.0001, Mann–Whitney U-test) and in SW group
(p = 0.0024, Mann–Whitney U-test). The average months in
the current job was higher in NE group (155.6 ± 151.4) in
comparison with the E group (74.9± 91.2) and SWgroup (67.6±
54.3). Regarding smokers (SW), the average number of cigarettes
smoked per day was 16.5 ± 7.5 (range 3–30), and the mean
number of years as a smoker was 22.9 ± 10.9 (range 3–49).
Most workers declared not being exposed to ETS out of the
work, namely at home, and have no other professional activity
where they could be occupationally exposed to ETS. Biological
monitoring of ETS exposure was assessed by measurement of the
urinary cotinine concentration, a metabolite of nicotine, using
gas chromatography–mass spectrometry, as previously reported
(17). As expected, the cotinine level was significantly increased
in SW comparatively to NSW (p < 0.0001, Mann–Whitney
U-test). The cotinine values obtained for non-smokers fall in the
range considered involuntary exposure (17, 67). Among them,
the mean cotinine level measured in the E group (7.98 ± 7.26
ng/mL) was significantly higher (p = 0.0005, Mann–Whitney
U-test) than in the NE workers group (2.23 ± 4.31 ng/mL, the
majority being below the level of quantification).
Biomarkers of Early Biological Effects
The results of the cytogenetic andDNAdamage effect biomarkers
studied are presented in Tables 2, 3. In peripheral blood
lymphocytes, no significant differences in the mean frequency
of SCE/cell and in the level of HFCs were observed between
the ETS-exposed (E) and NE groups. On the other hand,
when considering the effect of smoking, a significantly higher
percentage of HFCs was found in SW, comparatively to NE
(p = 0.003, Mann–Whitney U-test) or to ETS-exposed groups
(p = 0.016, Mann–Whitney U-test), although these differences
were not detected when similar comparisons were made using
the mean frequencies of SCEs (Table 2). The mean frequency
of MNBC per 1000 BC was significantly different in the E as
compared to the NE group (p= 0.004, Chi-square test) (Table 2).
Unexpectedly, non-smoking workers exposed to ETS showed a
27.3% reduction in the frequency ofMNBC in PBLs, as compared
to non-smoking NE workers. Also, the SW group presented
a significantly higher frequency of MNBC as compared with
the ETS-exposed group (p = 0.001, Chi-square test), but no
significant difference was detected between the group of SW and
the NE group (p = 0.53, Fisher’s Exact Test), both displaying a
similar frequency of MNBC.
As to the level of DNA damage assessed by the comet assay,
no differences in the percentage of DNA in tail or in the tail
length were observed neither between the E and NE groups
nor between SW and NSW groups (Table 3). In respect to the
ex vivo challenge assay with EMS, the data show that both
parameters, tail DNA and TL, were significantly different in ETS-
exposed comparatively to the NE group (p < 0.001, Mann–
Whitney U-test). The level of EMS-induced DNA damage was
26.6% lower in the E group, as compared to the NE group of
workers. The individual values of tail DNA for each worker,
from E or NE groups, is shown in Figure 1. After the ex vivo
EMS challenge assay, the distribution of the data points from
the E workers is always under a threshold of 36%, while NE
individuals show a wider range of DNA damage induction, up
to 57% (Figure 1). When comparing the SW with the ETS-
exposed group, a significant difference was also observed (p <
0.01, Mann–Whitney U-test), with the E group presenting the
lowest values of tail DNA and TL in challenged lymphocytes; no
difference was observed between the SW and the NE groups.
In Buccal exfoliated cells there were no significant differences
between the E and NE groups, neither in respect to the frequency
of MNC/1000 cells nor in NBUD/1000 cells. Considering
smoking, the SW displayed the lowest NBUD frequencies and
the comparison between the SW and NSW showed a significant
difference in the frequency of NBUD (p = 0.0004, Chi-square
test). A positive correlation was found between MNBC/1000 BC
in PBLs and MNC/1000 cells (p = 0.003, r = 0.527, Spearman’s
correlation) or NBUD/1000 cells (p = 0.0038, r = 0.5199,
Spearman’s correlation) in buccal cells in the E group, which was
not seen in other groups.
The impact of potential confounding factors was analyzed in
respect to each of the effect biomarkers considering the total
number of individuals studied, or after stratification by exposure.
In this sense, data for each biomarker were separately analyzed
according to gender, but no significant differences were observed,
in spite women presented a slightly increasedmean of SCEs when
compared to males (9.33 ± 1.48 vs.7.75 ± 1.31, respectively;
p = 0.071, Mann–Whitney U-test) and a slightly lower level
of DNA damage as assessed by the percentage of DNA in tail
(2.18 ± 0.31 vs. 3.38 ± 1.35, respectively; p = 0.076, Mann–
WhitneyU-test), only in the E group. None of the biomarkers was
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TABLE 1 | Characteristics of the study population.
Smoking workers Non-smoking workers
Variables (SW) (NSW)
NE E
Number of workers 19 33 29
Age (years)
Mean ± SD 39.1 ± 11.1 45.2 ± 12.2a 37.2 ± 10.8
Range 18–63 19–66 24–57
Gender (%)
Female 6 (38.6) 11 (33.3) 4 (13.8)
Male 13 (68.4) 22 (66.7) 25 (86.2)
Smoking habits
No. of cigarettes per day (Mean ± SD) 16.5 ± 7.5 – –
Range 3–30 – –
No. of years of smoking (Mean ± SD) 22.9 ± 10.9 – –
Range 3–49 – –
Other ETS exposure* (%)
Yes 4 (21.1) 3 (9.1) 7 (24.1)
No 12 (63.2) 30 (90.9) 17 (58.6)
No data 3 (15.8) – 5 (17.2)
Biomarker of exposure** (ng/ml)
Cotinine concentration (Mean ± SD) 1598.3 ± 806.9 2.2 ± 4.3 7.9 ± 7.3b
Range 237.0–3125.0 1–19.0 1–28.0
Working time characterization
Months in the current job (Mean ± SD) 67.6 ± 54.3 155.6 ± 151.4 74.9 ± 91.2
Range 3–180 2–468 1–408
Hour in a week of service (Mean ± SD) 47.5 ± 12.6 48.9 ± 12.3 39.1 ± 9.7c
Range 40–90 14–66 14–70
aMean NE significantly higher than E (p = 0.008, unpaired t-test); bMean E significantly higher than NE (p = 0.0005, Mann-Whitney U-test); cMean E significantly lower than NE (p
< 0.0001) and SW (p < 0.01) with Mann–Whitney U-test; *Exposure outside the workplace in the study, at home; **Methodology described in Pacheco et al. (17); Cotinine average
concentrations below the detection limit of the assay were assumed to be 0.1 ng/ml for analysis purpose (quantification limit is 5 ng/ml); SD, standard deviation.





NE E p-value, test
(NE vs. E)
n Mean ± SD n Mean ± SD n Mean ± SD
Lymphocytes
SCEs 19 9.01 ± 1.64 33 8.06 ± 0.92 29 7.97 ± 1.42 0.472, Mann–Whitney
HFCs 19 14.00 ± 9.48a 33 6.79 ± 4.77 29 8.00 ± 7.54 0.892, Mann–Whitney
MNBC/1000 BC 19 6.79 ± 4.09 32 6.22 ± 3.27 29 4.52 ± 2.71b 0.004, Chi-square test
CBPI 19 1.56 ± 0.14 32 1.59 ± 0.16 29 1.61 ± 0.16 0.767, Mann–Whitney
Buccal exfoliated cells
MNC/1000 cells 19 0.48 ± 0.59 32 0.49 ± 0.80 29 0.69 ± 0.90 0.306, Chi-square test
NBUD/1000 cells 19 0.31 ± 0.40c 32 0.85 ± 0.83 29 1.1 ± 0.83 0.318, Chi-square test
SD, standard deviation; SCE, sister chromatid exchange; HFC, high frequency cells; MNBC, micronucleated binucleated cells; BC, binucleated cells; CBPI, Cytokinesis-blocked
proliferation index; MNC, micronucleated cells; NBUD, nuclear buds; asignificantly different from NE (p = 0.003; Mann–Whitney U-test) and from E (p = 0.001; Mann–Whitney U-test);
bsignificantly different from SW (p = 0.001; Chi-square test); csignificantly different from both NE and E (p < 0.001, Chi-square test).
impacted by the age of the individuals. Regarding the smoking
habits, there was no influence of the number of cigarettes
smoked per day or the number of years of smoking in the
biomarkers analyzed. Also, no relationship was found between
the parameters that characterize the working time and the effect
biomarkers. Furthermore, there was no correlation between the
exposure biomarker (urinary cotinine concentration) and each
of the effect biomarker, when considering the whole group of
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n Mean ± SD n Mean ± SD n Mean ± SD (NE vs. E)
Basal
Tail DNA (%) 17 2.94 ± 0.94 32 2.93 ± 0.70 27 3.24 ± 1.34 0.738
Tail length (µm) 17 3.30 ± 1.64 32 3.13 ± 0.80 27 3.00 ± 0.90 0.523
EMS challenge
Tail DNA (%) 17 35.46 ± 7.48* 32 36.67 ± 10.93 27 26.89 ± 6.95 0.0001
Tail length (µm) 17 35.70 ± 6.83* 32 36.02 ± 8.09 27 29.18 ± 5.90 0.0001
SD, standard deviation; EMS, Ethyl Methanesulfonate; *Significantly different from E groups (p < 0.01, Mann–Whitney U-test).
FIGURE 1 | Distribution of the tail DNA from non-exposed (NE) or Exposed (E) workers with and without the in vitro challenge with Ethyl Methanesulfonate (EMS).
Each data point corresponds to one worker. Dashed line represents the mean value of DNA in tail for the NE, after challenge with EMS.
individuals or after their stratification according to exposure, i.e.,
E, NE, and SW groups.
Biomarkers of Susceptibility
The distribution of the genotype frequencies relative to the
metabolism and DNA repair genes in the studied groups
is presented in Table 4. The allelic frequencies of GSTP1105,
hOGG1326, XRCC1194, XRCC1399, XRCC3241, NBN 185, and
PARP1762 follow the Hardy-Weinberg conditions (p < 0.05,
Chi-square test), except the GSTP1105genotype on the ETS-
exposed group. In the study population, considering the
polymorphisms in the hOGG1326, XRCC1194, and PARP1762
genes, the prevalent allele was the common allele (+/+). In
addition, when considering the GSTT1 gene, the wild-type allele
was prevalent in the study population; the E group presented a
lower prevalence of the null genotype (17.24%) comparatively
to the NE (39.39%). For the GSTM1 gene both genotypes were
similarly present (Table 4). The distribution of the common
and variant alleles between the NE and E groups did not show
significant differences for any of the polymorphism analyzed
except for NBN 185 (p = 0.047, Fisher exact test), where the E
group presented a lower prevalence of the wild-type genotype.
No significant differences were observed between SW and E or
NE groups for all studied polymorphisms, although the GSTP1
Ile/Ile genotype was more prevalent in the E group (62.07%) than
in the SW (31.58%).
Influence of Genetic Susceptibility on
Effect Biomarkers
To ascertain the potential influence of the metabolism and
DNA repair genes genotype in the genotoxic outcomes, the
measurements of chromosome and DNA damage in individuals
carrying the common or the variant alleles were compared
both in the total study population and in each study group
(Tables 5, 6). When analyzing the total number of individuals
studied, irrespectively of the exposure condition, none of the
polymorphisms characterized significantly influenced the level
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TABLE 4 | Frequency of metabolism and DNA repair genotypes in the studied groups.





NE (%) E (%) (NE vs. E)
GSTP1105 Ile/Ile 41(50.6) 6 (31.58) 17 (51.52) 18 (62.07) 0.679a
Ile/Val 29 (35.8) 11 (57.89) 11 (33.33) 7 (24.14)
Val/Val 11 (13.6) 2 (10.53) 5 (15.15) 4 (13.79)
FA* 0.31 0.39 0.32 0.26
GSTM1 Present 41 (50.6) 7 (36.84) 17 (51.52) 17 (58.62) 0.617b
Absent 40 (49.4) 12 (63.16) 16 (48.48) 12 (41.38)
GSTT1 Present 58 (71.6) 14 (73.68) 20 (60.61) 24 (82.76) 0.091b
Absent 23 (28.4) 5 (26.32) 13(39.39) 5 (17.24)
XRCC1194 Arg/Arg 66 (81.5) 18 (94.74) 25 (75.76) 23 (79.31) 0.771b
Arg/Trp 15 (18.5) 1 (5.26) 8 (24.24) 6 (20.69)
Trp/Trp 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
FA* 0.09 0.03 0.12 0.1
XRCC1399 Arg/Arg 40 (49.4) 10 (52.63) 14 (42.42) 16 (55.17) 0.559a
Arg/Gln 35 (43.2) 9 (47.37) 15 (45.45) 11 (37.93)
Gln/Gln 6 (7.4) 0 (0.0) 4 (12.12) 2 (6.90)
FA* 0.29 0.24 0.35 0.26
XRCC3241 Thr/Thr 33 (40.7) 10 (52.63) 11 (33.33) 12 (41.38) 0.356a
Thr/Met 36 (44.4) 8 (42.11) 14 (42.42) 14 (48.28)
Met/Met 12 (14.8) 1 (5.26) 8 (24.24) 3 (10.34)
FA* 0.37 0.26 0.45 0.34
hOGG1326 Ser/Ser 57 (70.4) 12 (63.16) 27 (81.82) 18 (62.07) 0.096b
Ser/Cys 21 (25.9) 7 (36.84) 6 (18.18) 8 (27.59)
Cys/Cys 3 (3.7) 0 (0.0) 0 (0.0) 3 (10.34)
FA* 0.17 0.18 0.09 0.24
NBN185 Glu/Glu 40 (49.4) 10 (52.63) 20 (60.61) 10 (34.48) 0.047b
Glu/Gln 33 (40.7) 7 (36.84) 10 (30.30) 16 (55.17)
Gln/Gln 8 (9.9) 2 (10.53) 3 (9.09) 3 (10.34)
FA* 0.30 0.29 0.24 0.38
PARP1762 Val/Val 54 (69.2) 12 (70.59) 20 (60.61) 22 (75.86) 0.170b
Val/Ala 21 (26.9) 5 (29.41) 11 (33.33) 5 (17.24)
Ala/Ala 3 (3.9) 0 (0.0) 2 (6.06) 1 (3.45)
FA* 0.17 0.15 0.23 0.13
*FA - Frequency of the variant allele for each polymorphism, in the total population and in each studied group. The frequency of the variant allele was calculated considering the
heterozygous plus homozygous individuals having the variant allele; aStatistical analysis using Pearson Chi-Square (2-sided); bStatistical analysis using Fisher exact test (2-sided).
of the effect biomarkers (p > 0.05, Mann-Whitney) (data
not shown).
Considering the GSTP1, GSTM1, and GSTT1 polymorphisms,
no significant differences amongst the possible genotypes were
observed, within SW, NE or E groups, for the frequencies of
SCEs, MNBC or DNA strand breaks (% tail DNA). It may be
noted that, in the SW group, the frequencies of SCEs, HFCs
(data not shown) and MNBC were higher in the subjects with
the GSTP1 variant allele (only two individuals), comparatively
to those of the WT or heterozygous carriers. The E group
maintained the overall trend of lower MNBC comparatively
to both SW and NE group which was not influenced by
the genotype. On the other hand, SW individuals with the
GSTM1 allele present, showed significantly increased MNBC
when compared to E group, while GSTT1 wild-type individuals
from NE group presented increased MNBC when compared
to E group (P = 0.015, Mann-Whitney U-test). In respect to
the EMS-induced DNA damage, irrespective of the genotype,
the already observed lower levels of DNA damage in the E
group comparatively with the NE or SW group is maintained
either for the GSTP1, GSTM1, or GSTT1. However, workers’
stratification according to their genotype, lead to a lower
statistical power, due to the small samples size. This is reflected in
the GSTP1 and GSTM1, where for GSTP1 the difference between
the ETS-exposed and NE groups only became significant for
the subset of the WT allele carriers whereas for the GSTM1
polymorphism significance was detected for the comparison
between the null allele carriers. Interestingly, in the case of SW,
in the absence of the GSTT1, a lower level of DNA damage
was observed comparatively to GSTT1 wild-type individuals,
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TABLE 5 | Mean (± SD) frequencies of SCEs and MNBC in PBL in the studied groups stratified by genotypes.
SCEs MNBC
Genes Genotypes SW NSW p-value2 SW NSW p-value2
NE E (NE vs. E) NE E (NE vs. E)
GSTP1105 Ile/Ile 8.87 ± 1.26 8.29 ± 0.94 7.87 ± 1.08 0.222 4.50 ± 2.35 6.29 ± 2.93 4.94 ± 3.32 0.139
Ile/Val 8.53 ± 1.38 8.03 ± 0.70 8.25 ± 1.75 0.821 6.91 ± 3.96 6.60 ± 4.50 3.86 ± 1.07 0.257
Val/Val 12.02 ± 0.85 7.38 ± 1.12 7.92 ± 2.38 0.806 13.0 ± 2.82 6.22 ± 3.27 3.75 ± 0.96 0.076
p-value1 0.064 0.158 0.996 0.072 0.799 0.674
GSTM1 Present 9.20 ± 2.00 8.14 ± 0.77 7.69 ± 1.34 0.241 8.14 ± 3.24a 6.50 ± 3.56 4.65 ± 3.40 0.053
Absent 8.89 ± 1.48 7.98 ± 1.09 8.37 ± 1.45 0.763 6.00 ± 4.45 5.94 ± 3.04 4.33 ± 1.37 0.091
p-value2 0.933 0.679 0.223 0.097 0.879 0.445
GSTT1 Present 8.92 ± 1.63 8.11 ± 0.86 7.92 ± 1.54 0.346 6.60 ± 2.70 7.05 ± 3.56 4.63 ± 2.84 0.015
Absent 9.25 ± 1.84 7.98 ± 1.05 8.22 ± 0.57 0.693 6.86 ± 4.57 5.00 ± 2.45 4.00 ± 2.12 0.481
p-value2 0.711 0.754 0.386 0.963 0.096 0.907
XRCC1194 Arg/Arg 9.10 ± 1.64a 7.97 ± 0.99 7.90 ± 1.47 0.536 7.11 ± 3.95a 6.32 ± 3.31 4.91 ± 2.81 0.084
Arg/Trp 7.38 8.35 ± 0.63 8.23 ± 1.28 0.948 1.00 5.86 ± 3.34 3.00 ± 1.67 0.080
p-value2 – 0.208 0.518 – 0.800 0.107
XRCC1399 Arg/Arg 8.87 ± 1.34 8.00 ± 0.96 7.88 ± 1.30 0.574 7.10 ± 4.04a 5.79 ± 3.22 3.75 ± 1.48 0.080
Arg/Gln + Gln/Gln 9.15 ± 1.99 8.11 ± 0.92 8.07 ± 1.59 0.759 6.44 ± 4.36 6.56 ± 3.87 5.45 ± 3.55 0.250
p-value2 0.806 0.610 0.843 0.593 0.502 0.189
XRCC3241 Thr/Thr 8.69 ± 1.50 8.23 ± 0.58 8.13 ± 1.7 1 0.558 6.80 ± 4.37 6.50 ± 3.21 4.75 ± 2.01 0.141
Thr/Met + Met/Met 9.36 ± 1.80 7.98 ± 1.06 7.85 ± 1.21 0.671 6.78 ± 4.02a 6.09 ± 3.37 4.35 ± 3.16 0.041
p-value2 0.414 0.349 0.690 0.773 0.622 0.252
hOGG1326 Ser/ser 9.21 ± 1.46b 8.07 ± 0.95 8.32 ± 1.53 0.694 6.83 ± 4.13 6.59 ± 3.31 4.83 ± 2.83 0.024
Ser/Cys + Cys/Cys 8.65 ± 1.98 8.01 ± 0.88 7.40 ± 1.03 0.174 6.71 ± 4.35 4.20 ± 2.39 4.00 ± 2.53 0.818
p-value2 0.176 0.907 0.087 0.966 0.142 0.230
NBN185 Glu/Glu 8.75 ± 1.62 8.20 ± 0.76 8.22 ± 1.01 0.660 5.70 ± 2.91 5.79 ± 3.41 3.70 ± 1.83 0.116
Glu/Gln 9.21 ± 1.82a 7.82 ± 1.11 7.55 ± 1.46 0.580 8.43 ± 5.68 6.50 ± 3.34 5.19 ± 3.25 0.221
Gln/Gln 9.57 ± 1.82 7.93 ± 1.44 9.35 ± 1.73 0.275 6.50 ± 0.71 8.00 ± 2.00 3.67 ± 0.58 0.046
p-value1 0.697 0.399 0.184 0.623 0.364 0.405
PARP1762 Val/Val 9.31 ± 1.76 8.03 ± 1.10 7.95 ± 1.36 0.571 7.42 ± 4.36 6.15 ± 3.23 5.09 ± 2.79 0.147
Val/Ala + Ala/Ala 8.73 ± 1.61 8.11 ± 0.60 8.03 ± 1.85 0.335 5.00 ± 2.74 6.33 ± 3.47 3.00 ± 1.27 0.052
p-value2 0.527 0.854 0.654 0.365 0.922 0.041
1Statistical analysis using Kruskal–Wallis; 2Statistical analysis using Mann–Whitney U-test; asignificantly different from E group, within same genotype (p < 0.05, Mann-Whitney U-test);
bsignificantly different from NE group, within same genotype (p < 0.05, Mann–Whitney U-test).
an effect that was opposite of the observed in both E and
NE groups.
For the XRCC1194, XRCC1399 and XRCC3241, hOGG1326 and
NBN 185 polymorphisms, no significant influence of the genotype
was observed on the frequencies of SCEs, HFCs (data not
shown), MNBC or tail DNA, within NE, E, or SW groups. In
respect to PARP1762 polymorphism, a significant difference in
the frequency of MNBC was observed within the E group (p =
0.041), with the variant allele carriers showing a lower frequency
of micronucleated cells than the WT ones. Overall, the E group
maintained the trend of lower MNBC and EMS-induced DNA
damage comparatively to both SW and NE group.
DISCUSSION
Environmental tobacco smoke is a serious public health
concern, recognized as one of the most common indoor
pollutants worldwide. Many countries have already successfully
implemented smoke-free laws for indoor public spaces and
workplaces aimed at limiting exposure to ETS. In Portugal, since
2008, a partial smoke-free law is in place, allowing exceptions,
as for example in the case of restaurants, bars or discotheques
where smoking is allowed in smokers’ designated areas if
adequate reinforced ventilation systems are implemented. Thus,
exposure to ETS still happens in some Portuguese restaurants
and bars (16, 17, 19), meaning that workers remain at risk of
ETS exposure. Since tobacco smoke contains a great variety of
genotoxic/carcinogenic agents, this study aimed at characterizing
the local and systemic biomarkers of genotoxic effects associated
to occupational ETS exposure in a set of Lisbon restaurants and
bars and the potential influence of genetic polymorphisms on
those biomarkers. The quantification of employee’s exposure to
ETS and the self-reported smoking status was confirmed through
urinary cotinine measurement (17).
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TABLE 6 | Mean (± SD) values for basal and EMS tail DNA in the studied groups stratified by genotypes.
Basal tail DNA (%) EMS tail DNA (%)
Genes Genotypes SW NSW p-value2 SW NSW p-value2
NE E (NE vs. E) NE E (NE vs. E)
GSTP1105 Ile/Ile 3.00 ± 0.43 2.86 ± 0.68 3.56 ± 1.44 0.163 35.20 ± 8.31 39.05 ± 10.14 26.65 ± 7.37 0.000
Ile/Val 3.15 ± 1.06a 3.27 ± 0.75 2.26 ± 0.47 0.017 34.28 ± 7.23 35.11 ± 12.64 27.28 ± 6.25 0.104
Val/Val 1.78 ± 0.13 2.53 ± 0.37 3.36 ± 1.23 0.142 42.06 ± 6.87 31.71 ± 9.76 27.30 ± 7.88 0.327
p-value1 0.200 0.055 0.063 0.386 0.969 0.802
GSTM1 Present 2.60 ± 0.88 2.80 ± 0.62 3.53 ± 1.45 0.132 34.61 ± 7.10a 34.29 ± 13.69 26.34 ± 7.40 0.09
Absent 3.13 ± 0.96 3.07 ± 0.76 2.83 ± 1.08 0.236 35.93 ± 7.98a 39.05 ± 6.897 27.68 ± 6.50 0.001
p-value2 0.763 0.407 0.103 0.763 0.522 0.622
GSTT1 Present 3.15 ± 0.95 3.08 ± 0.64 3.27 ± 1.44 0.734 37.60 ± 7.53a 34.56 ± 11.91 26.19 ± 7.06 0.010
Absent 2.45 ± 0.79 2.71 ± 0.74 3.12 ± 0.84 0.349 30.35 ± 4.62b 39.75 ± 8.88 29.96 ± 6.11 0.016
p-value2 0.171 0.186 0.851 0.073 0.140 0.236
XRCC1194 Arg/Arg 2.94 ± 0.94 2.90 ± 0.66 3.29 ± 1.37 0.609 35.56 ± 7.48a 37.18 ± 10.89 26.84 ± 7.25 0.001
Arg/Trp – 3.05 ± 0.87 3.05 ± 1.28 0.808 – 34.87 ± 11.77 27.10 ± 6.13 0.123
p-value2 – 0.837 0.618 – 0.665 0.950
XRCC1399 Arg/Arg 3.12 ± 0.28 2.95 ± 0.51 3.21 ± 1.03 0.533 35.58 ± 7.69a 37.32 ± 12.64 26.30 ± 6.23 0.011
Arg/Gln + Gln/Gln 2.79 ± 1.28 2.92 ± 0.83 3.29 ± 1.74 0.893 35.37 ± 7.75 36.17 ± 9.75 27.74 ± 8.11 0.015
p-value2 0.290 0.849 0.622 0.847 0.820 0.693
XRCC3241 Thr/Thr 2.91 ± 0.69 3.03 ± 0.69 3.13 ± 1.17 0.725 34.30 ± 6.04 40.13 ± 11.88 28.82 ± 7.24 0.006
Thr/Met + Met/Met 2.98 ± 1.16 2.89 ± 0.71 3.32±1.46 0.515 36.50 ± 8.80a 35.10 ± 10.38 25.56 ± 6.64 0.004
p-value2 0.441 0.684 0.805 0.770 0.155 0.278
hOGG1326 Ser/ser 3.15 ± 1.01 2.88 ± 0.67 3.32 ± 1.43 0.66 33.93 ± 8,06 35.97 ± 11.17 28.56 ± 6.35 0.007
Ser/Cys + Cys/Cys 2.66 ± 0.80 3.24 ± 0.84 3.09 ± 1.18 0.641 37.66 ± 6.50a 40.47 ± 9.72 23.55 ± 7.23 0.014
p-value2 0.696 0.364 0.959 0.283 0.517 0.072
NBN185 Glu/Glu 3.09 ± 1.19 2.98 ± 0.84 2.79 ± 1.19 0.337 34.83 ± 6.52 34.83 ± 11.2 4 28.00 ± 6.50 0.058
Glu/Gln 2.84 ± 0.54 2.92 ± 0.48 3.65 ± 1.43 0.222 38.06 ± 9.18a 37.56 ± 9.98 25.41 ± 7.54 0.008
Gln/Gln 2.60 ± 0.86 2.93 ± 0.70 2.57 ± 0.43 0.513 30.53 ± 6.39 45.35 ± 10.93 30.95 ± 3.58 0.050
p-value1 0.796 0.796 0.163 0.454 0.388 0.290
PARP1762 Val/Val 2.91 ± 0.61 2.85 ± 0.67 3.26 ± 1.34 0.45 36.29 ± 7.30a 37.83 ± 10.44 26.13 ± 7.05 0.000
Val/Ala + Ala/Ala 3.07 ± 2.23 3.07 ± 0.75 3.15 ± 1.46 0.527 37.61 ± 8.75 34.73 ± 11.93 30.22 ± 5.95 0.399
p-value2 0.564 0.613 0.755 0.773 0.276 0.190
1Statistical analysis using Kruskal–Wallis; 2Statistical analysis using Mann–Whitney U-test; asignificantly different from E group, within same genotype (p < 0.05, Mann-Whitney U-test);
bsignificantly different from NE group, within same genotype (p < 0.05, Mann–Whitney U-test).
In the present study, no effect could be ascribed to ETS
exposure in relation to the basal level of DNA damage, as
assessed by the comet assay in leukocytes. A similar negative
result was obtained when comparing smokers to non-smokers,
irrespectively of the ETS exposure. The effect of smoking onDNA
damage has been thoroughly studied, mainly as a confounding
factor in biomonitoring studies addressing exposure to other
compounds (68, 69). Despite that, discrepant results have been
reported in the literature, either describing a lack of association
between smoking and DNA damage induction (the majority of
studies), as reviewed elsewhere (68–70) or an increased DNA
damage in smokers comparatively to non-smokers (37, 38, 71–
74). Very few studies have been published in respect to the
effect of ETS exposure on this biomarker and contradictory
results have been reported. In accordance with our results, in
peripheral blood lymphocytes of active and involuntary smoking
pregnant women, no significant difference was observed between
involuntary smokers and non-smokers, but smoking mothers
exhibited a statistically significant increase in DNA damage
comparatively to involuntary smokers (39). Moreover, newborns
displayed results similar to those found for their mothers (39).
An increase in DNA damage was reported in lymphocytes of
white-collar involuntary smokers and smokers at workplace,
comparatively to never smokers, although the mean value
obtained for involuntary smokers was similar to ours (38). A
similar observation was described in another study, in workers
from an elevator manufacturing factory in China, potentially
exposed to benzene, were passive smoking at home, but not at
the workplace, was significantly associated with DNA damage
(37). In children, a significant increase in DNA damage has
also been reported after exposure to ETS (41–43). No influence
of age or gender in the DNA damage was observed in our
study either in the total population or in the studied groups,
although women presented a slightly lower level of DNA damage,
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as assessed by the percentage of DNA in tail. The impact of
age on DNA damage is a matter of controversy, with either
positive or negative findings reported, which might depend of
different factors such as life-style, descriptors or statistics used,
as recently discussed (68). Regarding gender, the overall studies
have demonstrated no or equivocal difference between men and
women (68). Nevertheless, a study on the impact of ETS exposure
in non-smoking workers from casinos and bars in Las Vegas,
DNA-damage was significantly increased in a dose-dependent
manner with ETS exposure in non-smoker men but not in
women (10), in agreement with our finding.
Challenging lymphocytes ex vivo with a genotoxicant (e.g.,
EMS) and measuring induced primary DNA lesions with the
comet assay is a functional assay that allows an indirect
measurement of the DNA repair competence, which is critical
to prevent permanent genetic instability (75, 76). In fact, it
is well-known that abnormal DNA repair is a major cause
and is mechanistically involved in the development of cancer
(77, 78). In this study, blood cells exposure to a single EMS
dose allowed the identification of a differential responses in the
ETS-exposed group, which presented significantly lower levels
of DNA damage, comparatively to the NE and to SW groups.
This response suggests that leukocytes from involuntary smokers
somehow managed better the EMS-induced alkylating lesions,
promoting their rapid repair. In the study of Fracasso et al.
(38), lymphocytes of active and non-smokers exposed to ETS
challenged with an exogenous oxidative agent (i.e. H2O2-induced
DNA damage) showed that never smokers not exposed to ETS,
had the highest rates of repair of H2O2-induced breaks and
that the lymphocytes of active smokers exhibited a consistent
repair rate at the two administered doses (100 and 200µM),
slower that never smokers, possible due to the presence of
high levels of DNA lesions, hardly or not at all repaired (38).
However, the passive non-smokers displayed a reduced DNA
repair efficacy comparatively to ex-smokers exposed to ETS or
to active smokers. The reason for this distinct effect compared
to our results, might be related to the challenge agent used.
Vodicka et al. reported a higher irradiation-specific DNA repair
rate among highly exposed workers in a rubber tire plant and in
styrene-exposed lamination workers compared to unexposed or
moderately exposed workers (79, 80). The apparent increase in
DNA repair following a genotoxicant’s acute exposure may reflect
a general activation of the DNA repair machinery (79). A similar
effect was observed following exposure to benzene (81). In our
study, we hypothesize that cells from ETS-exposed individuals
may display an adaptive response after EMS challenging due
to the continuous low-level exposure to tobacco smoke that
works like the conditioning dose. The concept of adaptive
response is based on the observation that exposure of cells to
a low conditioning genotoxic insult (e.g., radiation, bleomycin,
mitomycin C, ethylnitrosurea) leads to their protection against
a subsequent higher (challenge) dose of the same genotoxicant,
an effect that may result from the upregulation of DNA repair
functions (82). For example, there are several lines of evidence
for an increase of O6-methylguanine-DNA methyltransferase
(MGMT) activity in the normal tissue of smokers compared
to non-smokers although these data awaits conclusive proofs
(83). However, Au et al. using the challenge assay, showed
that workers exposed to butadiene, pesticides and styrene, and
residents exposed to uranium mining and milling waste were
found to have significantly higher induction of chromosome
aberrations than the respective matched-controls, supposedly
due to impaired DNA repair capacity (77, 84).
Therefore, although in this study ETS exposure did not
affect the basal level of DNA damage, there is a suggestion
that it modulates the blood cells DNA repair response. It
remains to be determinedwhether increasedDNA repair capacity
in exposed individuals is truly induced, and if so whether
a threshold exists for this induction, and whether long-term
exposure could exhaust the induction as suggested by Vodicka
et al. (80). Furthermore, these findings suggest that ETS, activates
a response mechanism that counteracts the negative effects ETS
exerted on DNA and the preliminary investigation to try to
identify such mechanisms using a proteomic-based approach is
ongoing (19).
No increase in either the frequency of SCEs or HFC was
observed in ETS-exposed workers (involuntary smokers), as
compared to non-exposed workers. Our finding agrees with the
negatives data reported in previous studies in workers exposed
to ETS in restaurants (33) and in administrative companies
(35). The latter studied 106 adult non-smokers divided into
two groups according to whether they experienced high or low
levels of exposure to ETS as determined from plasma cotinine
levels. Nevertheless, in children, ETS exposure was associated
with increased SCE (27). On the other hand, it is recognized
that the measurement of SCEs in PBLs is a sensitive biomarker
of exposure to cigarette smoke (32, 33, 85–92). The cigarette
smoke effect was not observed in our study, mainly constituted
by light smokers (amount of daily cigarette consumption: 16.47
± 7.25; range 3–30). In that regard, a previous study in healthy
individuals, showed no differences between light smokers and
non-smokers, while the percentages of HFC were significantly
higher in smokers than in non-smokers (86). Other studies
also observed an effect of smoking in HFC but not in SCE
frequency, although only in 1,3-butadiene-exposed workers (93).
In our study, the proportion of HFCs was also significantly
higher in SW comparatively to the whole non-smokers group
and the same trend was observed after stratification into ETS-
exposed and NE workers. HFCs are considered relevant to assess
the genotoxicity of human chronic exposure to chemicals and
have been identified as long-lived lymphocytes which accumulate
persistent damage or as a subpopulation of lymphocytes with an
increased sensitivity to chemicals (87, 94). Therefore, analyzing
the percentage of HFC, as a “measure of SCE rate” may be more
sensitive than the mean of SCE to detect effects due to chemical
exposure, such as smoking, when an effect is not clearly detected
by differences in mean SCE value (95). Our results concerning
the influence of gender agree with published studies showing no
association with the SCE frequency (87, 92, 96), although positive
findings were also reported showing that women display a higher
frequency of SCE comparatively to men (85). Also, no influence
of age was observed in agreement with recent studies (85, 92).
Interestingly, a lower frequency of micronucleated cells was
found in PBLs of involuntary smokers, comparatively to NE or
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to SW groups, whereas NE and SW displayed a similar frequency
of MNBC. It is important to refer that the frequencies of MNBC
obtained for NE and SW groups were within the range of our
historical control values. Although this observation in the E
group was unexpected, other studies have reported that light
smokers (smoking <20 cigarettes per day) and former smokers
displayed slightly reducedMN frequencies in comparison to non-
smokers (21, 97). An explanation may rely on the fact that the
most damaged cells may not survive the culture period in the
CBMN assay or may not be able to divide and thus to express
chromosome breaks or loss as MN in cultured lymphocytes
(21, 97). Another hypothesis also pointed out by the same authors
to justify the lower frequency ofMN observed in the PBL of light-
medium smokers when comparedwith non-smokers, is that a few
cigarettes per day may stimulate an adaptive response, causing
an apparent lowering in the MN frequency, and a continued
exposure to mutagens/carcinogens may induce resistance to
further DNA damage (21, 97). This might be the case in our
study, since the observed lower frequency of MN in involuntary
smokers is compatible with the hypothesized increased capacity
of these workers to repair DNA strand breaks, following ex
vivo blood cells exposure to EMS. Taken together, the results
from both assays may suggest that continuous and repetitive
exposure to low level of ETS stimulates a cell-protective response.
However, it must stressed that the long-term health consequences
from this continuous stimulation cannot be foreseen. A study
addressing the effect of ETS exposure on children showed a 30%
increase in the frequency of MN (25), although caution should be
taken beforemaking extrapolations to adults, since children show
increased sensitivity to toxic substances when compared to adults
due to differences in chemicals detoxification and excretion
pathways (76, 98, 99). In this study, no induction of MNBC
was observed in SW as compared to the total NSW population
not stratified by ETS exposure. Although some authors reported
an increase in the MN frequency in smokers, our results agree
with those from a meta-analysis within the HUMN project, that
showed that smokers do not exhibit an overall increased MN
frequency when compared to non-smokers, which is normally
higher in heavy smokers not occupationally exposed to genotoxic
agents (21). This was also recently observed in other study (100).
Although the effect of age and gender on the MN levels in
lymphocytes is well-established, with women having higher levels
of MN than men and with MN levels progressively increasing
with age (97, 101, 102), that was not observed in our study,
possibly due to the sample size and the relatively young age of
the participants, mostly constituted by men.
The analysis of MN and NBUD in buccal cells, as a biomarker
of local effect, did not detect differences in the number of MNC
and NBUD between the E and NE groups, with both groups
presenting MN frequencies similar to the average reported for
healthy population (1–3 per 1,000 cells) (101–103). A positive
correlation between MN in buccal cells and MN in whole blood
lymphocytes was found in our study, but only for the E group.
This observation agrees with a recent analysis showing that
MN frequencies in exfoliated buccal cells correlate with those
analyzed in peripheral lymphocytes and that both are valid
biomarkers for increased cancer risk in humans (104, 105).
However, a decreased level of NBUD was seen in the SW group
comparatively to NSW, which might be related to a higher
turnover of the oral mucosa cells of smokers. Neither age or
gender influenced the level of MNC or NBUDs in our study.
Also, within the HUMN(XL), in an analysis of a database of 5,424
subjects with buccal MN values obtained from 30 laboratories
worldwide, no effect of gender was evident, while the trend for
age was highly significant (102).
The remaining confounding factors, either related to smoking
habits or working time did not influence the effect biomarkers
analyzed. Furthermore, there was no correlation between the
exposure biomarker (urinary cotinine concentration) and each
of the biomarkers of effect, when considering the whole group of
individuals or after their stratification according to exposure, i.e.,
E, NE, and SW groups.
Overall, the results of a set of biomarkers of early biological
effects showed that ETS did not induce DNA or chromosome
damage in blood cells from non-smoking exposed workers.
Furthermore, following an ex vivo acute genotoxic stimulus, ETS-
exposed individuals displayed a higher competence to repair
DNA damage than unexposed individuals, which might be
related with an adaptive response triggered by the prolonged
exposure to a low level of tobacco smoke components.
Genetic susceptibility biomarkers, such as the inherited
capacity for xenobiotic biotransformation and DNA damage
repair, indicate individual differences that can modulate the
response to genotoxic insults (46, 47). Thus, the association of
polymorphisms in relevant genes with biological effects following
exposure to environmental stressors represents a valuable tool
for assessing the individual sensitivity to that exposure, and
it may also influence the basal level of DNA or chromosome
damage (47, 50). Therefore, in this study, the influence of
genetic polymorphisms in genes associated with metabolism and
DNA repair on several genotoxicity endpoints was analyzed. For
most polymorphisms investigated, no influence was detected in
relation to any of the genotoxicity biomarkers within workers
from each of the studied groups, possibly due to small sample
size. The E group maintained the overall trend of lower MNBC
and EMS-induced DNA damage, comparatively to both SW
and NE group, which was not influenced by the genotype.
The only exception was PARP1762 polymorphism. PARP1 is an
enzyme involved in the cellular response mechanisms to DNA
damage. It participates in DNA base excision repair, single-
and double-strand break repair pathways, that are active in the
prevention of deletions/insertions induced by alkylating agents.
PARP1 polymorphism Val762Ala (rs1136410 T>C) may be
associated with prostate cancer (106), esophageal squamous cell
carcinoma (107), and breast cancer (108). Recent meta-analyses
found a borderline significant association between PARP1
Val762Ala polymorphism and overall cancer risk, although
after stratification by cancer types, the polymorphism could
predispose to gastric cancer, thyroid cancer and cervical cancer,
in an Asian population, but not in Caucasian and African
populations (109, 110). Involuntary smoking was associated
with an increased risk of breast cancer among both pre-
and postmenopausal women, depending on the genotype of
PARP1762 (111), while Ala762Ala (rs1136410 C/C) genotype
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was associated with an elevated risk of esophageal squamous
cell carcinoma in smokers compared to T/T or T/C genotype
(107, 112). In the present study, the PARP1762 homozygous wild-
type genotype modulated the MNBC frequency, which was lower
in variant carriers, within the E group. Considering the above-
mentioned studies, it would be expected that the variant allele
would rather be associated with increased MNBC frequency.
When looking at EMS-induced DNA damage, the PARP1762
variant allele carriers presented an increase of DNA damage
in E group comparatively to the wild-type carriers, although
not significant, due to small number of variant allele carriers.
It can be suggested that the partial suppression of PARP1
activity in the variant carriers might have led to an overload of
genetic damage in cells, triggering cell death mechanisms and
removal of most damaged cell, thereby masking a genotoxic
effect. Besides, a decreased MNCB frequency was observed
in the variant allele carriers from E group compared to NE,
similarly to the slight effect observed in E workers with normal
allele, thus suggesting a possible interaction between tobacco
smoke exposure and the genotype, in E group, in the genotoxic
outcome observed. According to recent meta-analyses, GSTM1
and GSTT1 deletion as been associated with lung cancer in
overall population (113, 114), while no correlation was observed
concerning GSTP1105, in overall population (115). Concerning
DNA repair-genes, based on meta-analysis, XRCC1399 and
XRCC1194 polymorphism were significantly associated with lung
cancer risk in caucasions (116), and NBS1195 in Asians, but not
caucasions (117). No relation with lung cancer was observed
either in XRCC3241 and hOGG1326 genotype subjects (118–120).
Overall, despite the influence of the studied polymorphisms in
the genotoxic biomarkers was not sharp when considering the
exposure groups stratification, some influence appears to exist
that needs however, to be further investigated in larger groups
of workers.
In the present study the results of genotoxicity biomarkers
used to assess the early biological effects of ETS in non-smoking
workers are presented. The most relevant effect detected in
restaurant workers exposed to indoor tobacco smoke was a
modified response to a genotoxic challenge, compatible with
an adaptive response. It remains to be determined, however,
whether the induction of this kind of response may have
long term consequences to the health of those workers. The
other effects biomarkers characterized in lymphocytes or oral
mucosa cells did not detect significant changes in ETS-exposed
comparatively to unexposed workers. Although the contribution
of individual susceptibility to the outcomes of this exposure
did not generate conclusive results, it deserves further attention.
Further investigation is also needed to better understand the
mechanisms underlying the possible adaptive response reported
in this work and its implication to human health. Ongoing
work will try to address the relationship between ETS exposure,
biomarkers of effect and alterations of the proteome.
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